As we age, levels of NAD⁺ — the compound required to support sirtuin gene function — are said to decline, which is considered one of the contributing factors to aging.

NAD⁺ levels are said to begin declining rapidly after the age of 30. Supplementing with NMN, the precursor to NAD⁺, is considered an effective approach for replenishing NAD⁺ levels in the body.

NMN supplementation is attracting worldwide attention for its potential in supporting approaches to aging and physical function.

While NMN is found in food, obtaining 100mg of NMN through diet alone would require approximately 1,600 heads of broccoli, 8,000 soybeans, or 240 tomatoes — making dietary intake alone impractical. For this reason, NAD⁺ infusion therapy was developed as a method to support more efficient NMN supplementation, allowing active ingredients to be taken directly into the body.

When comparing the same amount of NAD⁺ drip versus oral NMN intake, the NAD⁺ drip is considered to absorb high concentrations of NMN more rapidly.

With oral NMN intake, there is a possibility that NMN may be metabolized by liver enzymes before circulating throughout the body, making IV infusion the method considered to deliver active ingredients more efficiently.